Expanded Access:18F-Fluorocholine for the Detection of Parathyroid Adenomas
Sponsor: Thomas Hope
ClinicalTrials ID:NCT07218224
This expanded access protocol at UCSF allows patients aged 13 and older with primary hyperparathyroidism to access 18F-fluorocholine PET imaging. Participants must understand and sign informed consent. The intervention involves an intravenous dose of 4-7 mCi of 18F-Fluorocholine, followed by a PET scan to localize parathyroid adenomas. No health outcomes will be measured.
Patient Parameters
| Parameter | Options |
|---|
Program Overview
This expanded access protocol is proposed to allow University of California San Francisco (UCSF) patients additional access to 18F-fluorocholine (FCH) Positron Emission Tomography (PET) imaging for localization of parathyroid adenomas.
Description
No health outcome measures will be obtained under this protocol.
Eligibility Criteria
Inclusion Criteria
- Age ≥ 13 years.
- Evidence of primary hyperparathyroidism.
- Ability to understand a written informed consent document, and the willingness to sign it.
Exclusion Criteria
1. Unlikely to comply with protocol procedures, restrictions and requirements and judged by the Investigator to be unsuitable for participation.
Get This Program In Your Inbox
You can sign up and apply your patients for this program.